{
    "nctId": "NCT00806936",
    "title": "A 16-week Multicentre, Open Label, Non-interventional, Observational Study to Investigate the Status of Human Insulin or Insulin Analogue Treatments With Focusing on Efficacy and Safety in Type 2 Diabetes Subjects Inadequately Controlled With Two or More Oral Antidiabetic Drugs in China",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "After the investigator has taken the decision to use human insulin or insulin analogues to treat the subject"
                    },
                    {
                        "type": "variable",
                        "value": "any type 2 diabetic previously inadequately controlled with two or more OADs is eligible for the study"
                    },
                    {
                        "type": "variable",
                        "value": "The selection of the subjects will be at the discretion of the individual investigator"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Known or suspected allergy to trial product(s) or related products"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects who previously enrolled in this study"
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Females of childbearing potential who are pregnant"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "breast-feeding or intend to become pregnant or are not using adequate contraceptive methods"
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "The receipt of any investigational product within 3 months prior to this trial"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('After the investigator has taken the decision to use human insulin or insulin analogues to treat the subject'), Symbol('The selection of the subjects will be at the discretion of the individual investigator'), Symbol('any type 2 diabetic previously inadequately controlled with two or more OADs is eligible for the study'), Not(Or(Symbol('Known or suspected allergy to trial product(s) or related products'), Symbol('Subjects who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit'), Symbol('Subjects who previously enrolled in this study'), Symbol('The receipt of any investigational product within 3 months prior to this trial'), And(Symbol('Females of childbearing potential who are pregnant'), Symbol('breast-feeding or intend to become pregnant or are not using adequate contraceptive methods')))))"
}